Published on Novartis Ireland HCP Portal (https://www.hcp.novartis.ie)

Home > Printer-friendly > Divestments

Divestments [1]

Biosimilars

Erelzi® and Hyrimoz® divestment to Rowez Ltd.

Open [2]
Hospital Brands

Aclasta®, Atriance® and Hycamtin® Solution divestment to Rowex Ltd.

Open [3]
Retail Brands

Estradot®, TransidermNirto® and Hycamtin® capsules divestment to Rowex Ltd.

Open [4]
Rate this content: 
No votes yet
Source URL:https://www.hcp.novartis.ie/medicines/product-updates/divestments

Links
[1] https://www.hcp.novartis.ie/medicines/product-updates/divestments [2] https://www.hcp.novartis.ie/sites/hcp.novartis.ie/files/Change%20of%20Distribution%20to%20Rowex%20-%20Biosimilars.docx.pdf [3] https://www.hcp.novartis.ie/sites/hcp.novartis.ie/files/Change%20of%20Distribution%20Novartis%20to%20Rowex%20Ltd_%20Hospital%20%20Aclasta%20Atriance%20Hycamtin%20Sol.docx.pdf [4] https://www.hcp.novartis.ie/sites/hcp.novartis.ie/files/SIGNED%20Change%20Distribution%20Novartis%20to%20Rowex%20Ltd_%20Retail%20Pharmacists%20%28003%29%20Estradot%20Transiderm%20Nitro%20%20H.pdf